Structure Therapeutics Inc. (GPCR)
NASDAQ · Manufacturing · Pharmaceutical preparations
$35.93−$0.0900 (−0.25%) on the dayAs of the close; data may be delayed.
GPCR price, last 12 months
Key stats
- Previous close
- $36.02
- Open
- $36.29
- Day range
- $35.50 – $37.20
- 52-week range
- $24.54 – $94.90
- Volume
- 1.6M
- Avg volume (20 days)
- 1.3M
- Market cap
- $2.6B
Performance
1W+2.7%
1M−27.2%
3M−27.7%
6M−22.2%
YTD−48.3%
1Y+40.2%
vs S&P 500, 1Y+23.4 pts
Technicals and fundamentals
About Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $2.6B